Jennifer Pietenpol

May 21, 2020

State cancer plan has robust input and commitment from Vanderbilt-Ingram Cancer Center

More than a dozen representatives of Vanderbilt University Medical Center helped plan and made a commitment to help carry out the strategy for how Tennessee will prevent cancer and minimize its burden on state residents.

By Tom Wilemon
Research assistant Mahsa Majedi loads reagent used in DNA sample preparation in the genomics lab. She is part of a team of more than a dozen people at VUMC who are “sprinting” to develop — within 90 days — an antibody-based treatment to stop the spread of the Zika virus.
May 21, 2020

VUMC research ramps up in COVID-19 transition

As Nashville cautiously begins to emerge from its two-month-long COVID-19 Safer at Home response, so too are the labs and facilities at Vanderbilt University Medical Center.

By Bill Snyder
March 12, 2020

Triple-negative breast cancer drug therapy shows promise

Researchers from Vanderbilt-Ingram Cancer Center (VICC) discovered a role for MYCN in triple-negative breast cancer (TNBC), a particularly aggressive form of the disease, and identified a potential intervention for further clinical investigation.

By Tom Wilemon
February 27, 2020

Breast cancer study may help predict treatment response

Researchers at VUMC are reporting another advance in the understanding and treatment of triple-negative breast cancer, which is particularly aggressive and difficult to treat.

By Bill Snyder
October 24, 2019

Pietenpol, Wilson land Komen cancer research support

Two Vanderbilt-Ingram Cancer Center investigators have received financial support from Susan G. Komen for breast cancer research.

By Tom Wilemon
August 22, 2019

Grant strengthens breast cancer research efforts

Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding.

By Tom Wilemon
July 16, 2019

A critical factor for wound healing

Vanderbilt-Ingram Cancer Center scientists have discovered a role for a tumor suppressor protein in skin wound healing.
By Anivarya Kumar
April 18, 2019

Patient-centered design to be focus of StrategyShare19

StrategyShare19, an annual, interactive event at Vanderbilt University Medical Center to showcase innovations and initiatives to advance the Medical Center’s Strategic Directions, is focusing this year on Design for Patients and Families — one of the four Strategic Directions — and efforts to enhance patient, clinician and staff experiences.
By Jill Clendening
October 11, 2018

Cancer Center investigators awarded Komen grants

Four Vanderbilt-Ingram Cancer Center (VICC) investigators have received financial support from Susan G. Komen for breast cancer research.
By Tom Wilemon
June 28, 2018

Vanderbilt thinkers come together for StrategyShare18

Jun. 28, 2018—A multidisciplinary cross section of the Vanderbilt University Medical Center and Vanderbilt University community gathered Tuesday during StrategyShare18, an interactive half-day event to share ideas, invite collaborations and spur new initiatives.
By Jill Clendening
July 27, 2017

StrategyShare17 event helps build excitement, connections

On the same day 48 years after the July 20, 1969, Apollo 11 moon landing, individuals from throughout the Vanderbilt community reflected on that historic event — a milestone marking the ultimate synthesis of innovative thinking and technology — as they shared their own explorations and mission moments during StrategyShare17.
By Jill Clendening
April 6, 2017

Vanderbilt’s Pietenpol joins Sledge as a Chief Scientific Advisor for Susan G. Komen

Jennifer Pietenpol, Ph.D., Executive Vice President for Research at Vanderbilt University Medical Center (VUMC) and director of Vanderbilt-Ingram Cancer Center (VICC), has been named a Chief Scientific Advisor (CSA) for the nonprofit breast cancer organization Susan G. Komen.
By VUMC News and Communications
January 17, 2017

Vanderbilt-Ingram Cancer Center supports national HPV vaccination efforts

Nearly 39,000 new cancers associated with the human papillomavirus (HPV) will be diagnosed in the United States this year. Although HPV vaccines can prevent the majority of these cancers, vaccination rates remain low across the country.
By VUMC News and Communications
1 2 3 4 5